Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors

Journal of Surgical Oncology

Volumn 75, Issue 2, 2000, Pages 131-135

  Yoshida, Seiichi ^a   Morii, Ken ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Brain tumor; Cancer metastasis; Serum soluble interleukin 2 receptor

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN CANCER; BRAIN LYMPHOMA; BRAIN METASTASIS; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SOLUBILITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033759536     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200010)75:2<131::AID-JSO10>3.0.CO;2-L     Document Type: Article

References (22)

1. T-cell growth factor and the culture of cloned functional T-cells
2. Transmembrane signaling through hematopoietic receptors: Interleukin-2 and erythropoietin
3. Interleukin 2 receptors are released by cells in vitro not in vivo. I. Detection of soluble IL-2 receptors in cell culture supernatant and serum of mice by an immunoradiometric assay
4. Soluble interleukin 2 receptors released from activated human lymphoid cells in vitro
5. The soluble interleukin-2 receptor: Biology, function, and clinical application
6. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2
7. Increased levels of soluble interleukin-2 receptors in serum of patients with cancer
8. Soluble IL-2 receptor levels in patients with Graves ophthalmopathy
9. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
10. 2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma
11. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T-cell response in patients with advanced ovarian cancer
12. Soluble IL-2 receptors in AIDS
13. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies
14. Role of interleukin-2 receptors in immunologic monitoring following cardiac transplantation
15. Regression models and life-tables
16. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer
17. In vivo administration of purified human interleukin-2 to patients with cancer: Development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration
18. In vivo administration of purified human interleukin-2. I. Half-life and immunologic effects of Jurka T-cell line derived IL-2
19. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastasis to the liver
20. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma
21. Increased expression of cytokines in liver and serum in patients with extrahepatic diseases
22. The interleukin-2 receptor β chain is shared by IL-2 and a cytokine, previously designated IL-T, that stimulates the proliferation and the induction of lymphokine activated killer cells